New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications

Cited by (561)

Items 401–500 of 561

1. Epidemiology of COVID-19 outbreaks in aged care facilities during postvaccine period: a systematic review and meta-analysis
   Mohammad Rashidul Hashan, Nicolas Roydon Smoll, Gwenda Chapman, Catherine L. King, Jacina Walker, Michael Kirk, Delwar Akbar, Robert Booy, Gulam Khandaker · 2024 · BMJ Open
2. Asymptomatic Hypoxemia as a Characteristic Symptom of Coronavirus Disease: A Narrative Review of Its Pathophysiology
   Kiichi Hirota, Taku Mayahara, Yosuke Fujii, Kenichiro Nishi · 2022 · COVID
3. Impacto de las variantes genéticas de la espícula en las vacunas frente al SARS-CoV-2
   Jordi Reina, Pablo Arturo Fraile-Ribot · 2021 · Vacunas
4. Inhibitor screening of Spike variants reveals the heterogeneity of neutralizing antibodies to COVID-19 infection and vaccination
   Xiao-Mei Zhang, Mei-Huei Zheng, T. Liang et al. · 2021 · medRxiv
5. Antibodies Induced by Homologous or Heterologous Inactivated (CoronaVac/BBIBP-CorV) and Recombinant Protein Subunit Vaccines (ZF2001) Dramatically Enhanced Inhibitory Abilities against B.1.351, B.1.617.2, and B.1.1.529 Variants
   Xuesong Xu, Yi Hong, Erjing Chen, Yaping Wang, Biao Ma, Jiali Li, Wei Su, Yuxin Zhou, Mingzhou Zhang · 2022 · Vaccines
6. Chemosensory deficits are best predictor of serologic response among individuals infected with SARS-CoV-2
   Jonathan B. Overdevest, Alexandria L. Irace, Valeria Mazzanti, Eun Jeong Oh, Paule V. Joseph, Davangere P. Devanand, Zachary C. Bitan, Eldad A. Hod, David A. Gudis, Codruta C. Chiuzan · 2022 · PLoS ONE
7. An immunologist's perspective on anti-COVID-19 vaccines
   Tomas Milota, Zuzana Ozaniak Strizova, Jitka Smetanová, Anna Sediva · 2021 · Current Opinion in Allergy and Clinical Immunology
8. Analysing the impact of the two most common SARS-CoV-2 nucleocapsid protein variants on interactions with membrane protein in silico
   Syeda Tasnim Quayum, Saam Hasan · 2021 · Journal of Genetic Engineering and Biotechnology
9. Randomised trials of COVID-19 vaccines in Africa – charting the path forward
   Charles Shey Wiysonge, Duduzile Edith Ndwandwe, Lindi Mathebula, Ameena Ebrahim Goga, Glenda Gray · 2022 · South African Journal of Science
10. Viral immunogenic footprints conferring T cell cross-protection to SARS-CoV-2 and its variants
    Eduardo Cheuiche Antonio, Mariana Rost Meireles, Marcelo Alves de Souza Bragatte, Gustavo Fioravanti Vieira · 2022 · Frontiers in Immunology
11. A colorimetric reverse-transcription loop-mediated isothermal amplification method targeting the L452R mutation to detect the Delta variant of SARS-CoV-2
    Narin Thippornchai, Sukanya Pengpanich, Wansadaj Jaroenram, Nathamon Kosoltanapiwat, Passanesh Sukphopetch, Wansika Kiatpathomchai, Pornsawan Leaungwutiwong · 2024 · Scientific Reports
12. Vaccines: New challenges, new paradigms, new opportunities: Report of the 22nd DCVMN Annual General Meeting
    Rajinder Kumar Suri, Benoit Hayman, S. Prasad · 2022 · Vaccine
13. The distribution of COVID-19 mortality
    Michele Campolieti, Arturo Ramos · 2022 · Infectious Disease Modelling
14. Two Opposing Roles of SARS-CoV-2 RBD-Reactive Antibodies in Pre-Pandemic Plasma Samples From Elderly People in ACE2-Mediated Pseudovirus Infection
    Kyu-Young Sim, Gwang-Hoon Ko, So-Eun Bae, Kyu Yeong Choi, Jung Sup Lee, Byeong Chae Kim, Kun Ho Lee, Mi‐Ryoung Song, Sung‐Gyoo Park · 2022 · Frontiers in Immunology
15. On forecasting of COVID-19 transmission in Saudi Arabia and Egypt using reservoir computing model
    A. A. Elsadany, Abdullah Aldurayhim, Amr Elsonbaty · 2023 · Alexandria Engineering Journal
16. Implementation of a qPCR assay coupled with genomic surveillance for real-time monitoring of SARS-CoV-2 variants of concern.
    Natalia Rego, Alicia Costábile, Mercedes Paz et al. · 2021 · medRxiv
17. The Impact of Demographic, Clinical Characteristics and the Various COVID-19 Variant Types on All-Cause Mortality: A Case-Series Retrospective Study
    Faryal Ali Khamis, Salah Thabit Al Awaidy, Muna Ba’Omar, Wessam Osman, Shabnam Chhetri, Zaiyana Ambusaid, Zakariya Al Fahdi, Jaber Al Lawati, Khalsa Al Sulaimi, Salma Ali Al Bulushi et al. · 2022 · Diseases
18. Dentists' Stress During the COVID-19 Pandemic: A Repeated Cross-Sectional Study
    Athikhun Praditpapha, Nikos Mattheos, Pagaporn Pantuwadee Pisarnturakit, Atiphan Pimkhaokham, Keskanya Subbalekha · 2023 · International Dental Journal
19. A global blockchain for recording high rates of COVID-19 vaccinations
    Jorge H. Medina, Roberto Rojas‐Cessa, Ziqian Dong, Vatcharapan Umpaichitra · 2023 · Computers in Biology and Medicine
20. Herd immunity: challenges and the way forward in Korea
    Jiyoung Oh, Sohyun Kim, Boyeong Ryu, Minjoung Shin, Bryan Inho Kim · 2021 · Epidemiology and Health
21. Safety and immunogenicity of a recombinant DNA COVID-19 vaccine containing the coding regions of the spike and nucleocapsid proteins: Preliminary results from an open-label, phase 1 trial in healthy adults aged 19-55 years
    J. Ahn, Jeongsoo Lee, Y. Suh et al. · 2021 · medRxiv
22. Supervised Machine Learning Approach to Identify Early Predictors of Poor Outcome in Patients with COVID-19 Presenting to a Large Quaternary Care Hospital in New York City
    Jason E Zucker, Angela Gomez‐Simmonds, Lawrence J. Purpura, Sherif M Shoucri, Elijah D. LaSota, Nicholas E. Morley, Brit Sovic, Marvin Castellon, Deborah Theodore, Logan Bartram et al. · 2021 · Journal of Clinical Medicine
23. Update of the recommendations of the Sociedade Portuguesa de Cuidados Intensivos and the Infection and Sepsis Group for the approach to COVID-19 in Intensive Care Medicine.
    João João Mendes, José Artur Paiva, Filipe André Gonzalez, Paulo Mergulhão, Filipe Froes, Roberto Roncon, João Gouveia · 2021 · PubMed Central
24. A review of SARS-CoV-2 virology, vaccines, variants and their impact on the COVID-19 pandemic
    Tetsuyuki Hirahata, Reeshan ul Quraish, Afraz ul Quraish, Shahan ul Quraish · 2024 · Reviews in Medical Microbiology
25. Omicron and other variants of SARS-CoV-2 roles of vaccines and herd immunity in protecting from the emerging strains
    Manas Vaibhav Pustake, Purushottam Giri, Mohammad Arfat Ganiyani, Krishna Deshmukh · 2022 · Journal of Family Medicine and Primary Care
26. Non-neutralizing antibodies against SARS-CoV-2 nucleocapsid protein mediate variant transcendent antibody-dependent cellular cytotoxicity
    Anthonia E Osuagwu, Michael Payne, Jürgen Bosch, Uri R. Mbonye, Kien Nguyen, Jonathan Karn, Anna M. Bruchez, Christopher L. King · 2025 · The Journal of Immunology
27. The mother of all battles: Viruses vs humans. Can humans avoid extinction in 50–100 years?
    Eleftherios P. Diamandis · 2022 · Open Life Sciences
28. COVID-19 precautionary practices and associated factors among clients visiting a tertiary hospital, Addis Ababa, Ethiopia
    2022
29. Antibody screening at reduced pH enables preferential selection of potently neutralizing antibodies targeting SARS‐CoV ‐2
    Bharat Madan, Eswar R. Reddem, Pengfei Wang, Ryan G. Casner, Manoj S. Nair, Yaoxing Huang, Ahmed S. Fahad, Matheus Oliveira de Souza, Bailey B. Banach, Sheila N. López Acevedo et al. · 2021 · AIChE Journal
30. The changing impact of vaccines in the COVID-19 pandemic
    Jamie A. Cohen, Robyn M. Stuart, Jasmina Panovska‐Griffiths, Edinah Mudimu, Romesh Abeysuriya, Cliff C. Kerr, Michael Famulare, Daniel J. Klein · 2022 · medRxiv
31. Proposing a nasal trehalose‐induced autophagy approach against SARS‐CoV 2
    M. Pajokh, Mohammad Pourfridoni · 2021 · Health Science Reports
32. Inhibitor screening using microarray identifies the high capacity of neutralizing antibodies to Spike variants in SARS-CoV-2 infection and vaccination
    Xiaomei Zhang, Mei Zheng, Te Liang, Haijian Zhou, Hongye Wang, Jiahui Zhang, Jing Fei Ren, Huoying Peng, Siping Li, Haodong Bian et al. · 2022 · Theranostics
33. Current molecular diagnostics assays for SARS-CoV-2 and emerging variants
    Jonathan M. Banks, Kristelle J. Capistrano, Pari Thakkar, Hemangi Ranade, Vaidik Soni, Manali Datta, Afsar Raza Naqvi · 2022 · Methods in microbiology
34. COVID-19 endgame: from pandemic to endemic? Vaccination, reopening and evolution in a well-vaccinated population
    Elisha B. Are, Yexuan Song, Jessica E. Stockdale, Paul F. Tupper, Caroline Colijn · 2021 · medRxiv
35. Quarantine and testing strategies to ameliorate transmission due to travel during the COVID-19 pandemic: a modelling study
    C. Wells, Abhishek Pandey, Meagan C. Fitzpatrick · 2021 · medRxiv
36. Biophysical and Biochemical Characterization of the Receptor Binding Domain of SARS-CoV-2 Variants
    Ritika Khatri, Hilal Ahmad Parray, Gazala Siddiqui, Adarsh Kumar Chiranjivi, Sneha Raj, Rachel Kaul, Vikas Maithil, Sweety Samal, Shubbir Ahmed · 2022 · The Protein Journal
37. Engineered High-Affinity ACE2 Peptide Mitigates ARDS and Death Induced by Multiple SARS-CoV-2 Variants
    2021
38. Insights on the SARS-CoV-2 genome variability: the lesson learned in Brazil and its impacts on the future of pandemics
    Victória Riquena Grosche, Igor Andrade Santos, Giulia Magalhães Ferreira, João Victor Rodrigues Dutra, Larissa Catharina Costa, Nilson Nicolau-Júnior, Artur T. L. Queiroz, Diego Pandeló José, Ana Carolina Gomes Jardim · 2021 · Microbial Genomics
39. CRISPR screens for host factors critical for infection by SARS-CoV-2 variants of concern identify GATA6 as a central modulator of ACE2
    Ma’ayan Israeli, Yaara Finkel, Yfat Yahalom-Ronen, Nir Paran, Theodor Chitlaru, Ofir Israeli, Inbar Cohen-Gihon, Moshe Aftalion, Reut Falach, Uri Elia et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
40. Endoscopy After the COVID-19 Pandemic—What Will Be Different?
    Rashid Nok-Shun Lui, Raymond S. Y. Tang, Philip Wai Yan Chiu · 2022 · Current Treatment Options in Gastroenterology
41. Riding the waves of COVID-19 pandemics – A call for a multiobjective compromise
    E. Bignami, Davide Manca, Valentina Bellini · 2021 · Trends in Anaesthesia and Critical Care
42. Controlling long-term SARS-CoV-2 infections is important for slowing viral evolution
    Debra Van Egeren, Alexander Novokhodko, M. Stoddard · 2021 · medRxiv
43. Investigating the competition between ACE2 natural molecular interactors and SARS-CoV-2 candidate inhibitors
    Edoardo Milanetti, Mattia Miotto, Leonardo Bo’, Lorenzo Di Rienzo, Giancarlo Ruocco · 2023 · Chemico-Biological Interactions
44. Temporal trends of severity and outcomes of critically ill patients with COVID-19 after the emergence of variants of concern: A comparison of two waves
    Daniela Helena Machado Freitas, Eduardo Leite Vieira Costa, Natalia Zimmermann, Larissa Santos Oliveira Gois, Mirella Vittig Alves Anjos, Felipe Gallego Lima, Pâmela dos Santos Andrade, Daniel Joelsons, Yeh‐Li Ho, Flavia Cristina da Silva Sales et al. · 2024 · PLoS ONE
45. The specter of Manaus: the risks of a rapid return to pre-pandemic conditions after COVID-19 vaccine rollout
    Debra Van Egeren, M. Stoddard, Alexander Novokhodko · 2021 · medRxiv
46. Insights into the role of dynamical features in protein complex formation: The case of SARS-CoV-2 spike binding with ACE2
    Greta Grassmann, Mattia Miotto, F. Alessandrini, Leonardo Bo’, G. Ruocco, E. Milanetti, A. Giansanti · 2025 · Computational and Structural Biotechnology Journal
47. Serum from COVID-19 patients early in the pandemic shows limited evidence of cross-neutralization against variants of concern
    Amanda J. Griffin, Kyle Lee O’Donnell, Kyle Shifflett · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
48. Murine antibody 4B1D3 exhibits broad cross-reactivity and neutralizing activity against SARS-CoV-2 variants
    Mariângela de Oliveira Silva, Isabela Pazotti Daher, Catarina Harumi Oda Ibrahim, Edmárcia Elisa de Souza, Edilberto Postól, Raquel Elaine de Alencar, Guilherme Antônio de Souza Silva, Rodolfo Ferreira Marques, Flávia Lopes Adami, Viviane Schuch et al. · 2025 · Virology
49. Investigating expressed RNA variants that are related to disease severity in SARS-CoV-2-infected patients with mild-to-severe disease
    Javan Okendo, D. Okanda · 2022 · Egyptian Journal of Medical Human Genetics
50. Post-exposure Lopinavir-Ritonavir Prophylaxis versus Surveillance for Individuals Exposed to SARS-CoV-2: The COPEP Pragmatic Open-Label, Cluster Randomized Trial
    Niklaus Daniel Labhardt, Mikaëla Smit, Ianis Petignat, Thomas Perneger, Annalisa Marinosci, Pilar Ustero, Maria Pia Diniz Ribeiro, Silvio Ragozzino, Giovanni Jacopo Nicoletti, Pietro Benedetto Faré et al. · 2021 · EClinicalMedicine
51. Complex Pathophysiological Mechanisms and the Propose of the Three-Dimensional Schedule For Future COVID-19 Treatment
    Yonggang Zhou, Xiuxiu Xu, Haiming Wei · 2021 · Frontiers in Immunology
52. Preparation and Characterization of Inhalable Ivermectin Powders as a Potential COVID-19 Therapy
    Ahmed H Albariqi, Wei-Ren Ke, D. Khanal · 2022 · Journal of Aerosol Medicine
53. SARS-CoV-2 Variants of Concern Increased Transmission and Decrease Vaccine Efficacy in the COVID-19 Pandemic in Palembang Indonesia.
    Ahmad Ghiffari, Chairil Anwar, Hamzah Hasyim, Iskhaq Iskandar, Muhammad Totong Kamaluddin · 2022 · Acta bio-medica dell'Ateneo parmense/Acta biomedica
54. Serum from COVID-19 patients early in the pandemic shows limited evidence of cross-neutralization against variants of concern
    Amanda J. Griffin, Kyle Lee O’Donnell, Kyle Shifflett, John‐Paul Lavik, Patrick M. Russell, Michelle K. Zimmerman, Ryan F. Relich, Andrea Marzi · 2022 · Scientific Reports
55. Live virus neutralization testing in convalescent and vaccinated subjects against 19A, 20B, 20I/501Y.V1 and 20H/501.V2 isolates of SARS-CoV-2
    Claudia Gonzalez, Carla Saade, A. Bal et al. · 2021 · medRxiv
56. An Initial Spatiotemporal Assessment of COVID-19 Clusters in Nepal
    B. Acharya, S. Adhikari, Shreejana Pandit · 2022 · Journal of Institute of Science and Technology
57. Mask-off policy in the shadow of emerging variants of SARS-COV-2
    A. Shahraki, M. Vahed, M. Mirsaeidi · 2021 · European journal of internal medicine
58. Cross‐cultural investigation of the relationship between social identity, trusting the system, COVID ‐19 vaccine adherence and conspiratorial beliefs
    Evan A. Valdes, Junix Jerald I. Delos Santos, James Hou-fu Liu · 2025 · Asian Journal Of Social Psychology
59. Pediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 symptoms in Iran
    Mehran Akbari, M. Didehdar, M. Nazari · 2021 · Future Virology
60. Laboratory parameters associated with prolonged hospital length of stay in COVID-19 patients in Johannesburg, South Africa
    Jayandiran Pillai, Pradeep Pravinkumar Mistry, Dirk Andries le Roux, Keolebogile Shirley Motaung, Mathildah Mpata Mokgatle, P Gaylard, Nezerith Cengiz, Debashis Basu · 2022 · South African Medical Journal
61. Epidemiological profile of COVID-19 in the French overseas department Mayotte, 2020 to 2021
    M. Subiros, Charlotte Robert De Latour, Fanny Parenton et al. · 2022 · Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
62. Increased Risk of Severe COVID-19 in Hospitalized Patients With SARS-CoV-2 Variant of Concern Alpha Infection in France: A Multicentre Matched Cohort Study With Retrospective Data Collection
    Guillaume Martin‐Blondel, François-Xavier Lescure, Lambert Assoumou, Charlotte Charpentier, Jean-Marc Chapplain, Thomas Perpoint, Gaspard Grouteau, Hugues Cordel, Gilles Pialoux, Jérôme Pacanowski et al. · 2021 · BMC Infectious Diseases
63. Special Collection: Highlights of Medical, Urban and Veterinary Entomology. Highlights in Medical Entomology, 2021
    Andrea Gloria‐Soria · 2022 · Journal of Medical Entomology
64. Bioinformatic analysis of B and T cell epitopes from SARS-CoV-2 Spike, Membrane and Nucleocapsid proteins as a strategy to assess possible cross-reactivity between emerging variants, including Omicron, and other human coronaviruses
    Diana Laura Pacheco-Olvera, Stephanie Saint Remy-Hernández, María Guadalupe García-Valeriano, Tania Rivera-Hernández, Constantino III Roberto López-Macías · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
65. Spread of SARS-CoV-2 Delta variant infections bearing the S:E484Q and S:T95I mutations in July and August 2021 in France
    Laura Verdurme, Gonché Danesh, Sabine Trombert‐Paolantoni, Mircea T. Sofonea, Valérie Noel, Vincent Foulongne, Brigitte Montès, Édouard Tuaillon, Stéphanie Haïm‐Boukobza, Bénédicte Roquebert et al. · 2021 · medRxiv
66. Towards robust immune responses after heterologous COVID-19 vaccination and its application perspectives
    Yong Lin, Ai-long Huang · 2022 · National Science Open
67. Continuing COVID-19 Vaccination of Front-Line Workers in British Columbia with the AstraZeneca Vaccine: Benefits in the Face of Increased Risk for Prothrombotic Thrombocytopenia
    Amin Adibi, Mohammad Mozafarihashjin, M. Sadatsafavi · 2021 · medRxiv
68. Covid-19 genomic analysis reveals clusters of emerging sublineages within the delta variant
    Evans K. Rono · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
69. Immune Persistence against SARS-CoV-2 after Primary and Booster Immunization in Humans: A Large-Scale Prospective Cohort Study
    Juan Li, Hui Xie, Weixin Chen, Meng Chen, Shuang Bai, Wei Zhao, Tao Zhou, Pei Gao, Lichi Zhang, Quanyi Wang et al. · 2022 · Vaccines
70. Assessment of the feasibility of pool testing for SARS-CoV-2 infection screening
    Irene Paganini, Cristina Sani, Chiara Chilleri, Michela Baccini, Alberto Antonelli, Simonetta Bisanzi, Elena Burroni, Filippo Cellai, Marco Coppi, Fabrizia Mealli et al. · 2022 · Scandinavian Journal of Infectious Diseases
71. Evolution of SARS-CoV-2 in the RhineNeckar/Heidelberg Region 01/2021 07/2023
    Christian Bundschuh, N. Weidner, Julian A. F. Klein et al. · 2023 · medRxiv
72. Recent progress in CRISPR-based paper sensors for nucleic acid detection
    Yuqing Liu, Zunzhong Ye, Rui Wang · 2026 · Trends in Analytical Chemistry (TrAC)
73. RASCL: Rapid Assessment Of SARS-CoV-2 Clades Through Molecular Sequence Analysis
    Lucaci, Alexander G, Zehr, Jordan D, Shank, Stephen D, Bouvier, Dave, Mei, Han, Nekrutenko, Anton, Martin, Darren P, Kosakovsky Pond, Sergei L · 2022
74. The Recent Updates on Neoteric Variants of Covid-19 Virus and Therapeutic Effectiveness of Vaccines against the Variants.
    Sachin Chaudhary, Abdel‐Nasser El‐Shorbagi, Anurag Chaudhary, Garima Agarwal, Prabhash Nath Tripathi, Shweta Dumoga · 2022 · Biomedical & Pharmacology Journal
75. SARS-CoV-2 Immunity: Review of Immune Response to Infection and Vaccination
    Rahnuma Ahmad · 2021 · Bangladesh Journal of Medical Science
76. Re: “Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2” by Krsak et al.
    Martin Krsak, B. Harry, B. Palmer · 2021 · Viral immunology
77. Estimating infection-related human mobility networks based on time series data of COVID-19 infection in Japan
    Tetsuya Yamada, Shoi Shi · 2021 · medRxiv
78. SARS-CoV-2 most concerning variants: A review on their complications, pathogenicity, transmissibility, and immune responses
    Zeinab Mohseni Afshar · 2022 · Eurasian Journal of Pulmonology
79. Understanding Reasons for Vaccination Hesitancy and Implementing Effective Countermeasures: An Online Survey of Individuals Unvaccinated against COVID-19
    Y. Kobashi, Makoto Yoshida, Hiroaki Saito · 2024 · Vaccines
80. Analysis of the docking property of host variants of hACE2 for SARS-CoV-2 in a large cohort
    Hyojung Paik, Jimin Kim, Sangjae Seo · 2022 · PLoS Computational Biology
81. Scalability Analysis of a Global Blockchain For Immunization Records
    Jorge Medina, R. Rojas-Cessa, Ziqian Dong · 2022 · arXiv.org
82. Bean extract-based gargle for efficient diagnosing COVID-19 at early-stage using rapid antigen tests: a clinical, prospective, diagnostic study
    J. Kwon, Euna Ko, Se-Young Cho et al. · 2021 · medRxiv
83. SARS-CoV-2 variants, a still unfinished story
    Marta Pérez-Abeledo, J.C. Sanz Moreno · 2021 · Vacunas (English Edition)
84. Smart Nanostructured Materials for SARS-CoV-2 and Variants Prevention, Biosensing and Vaccination
    Lifeng Wang, Zhi-Wei Li · 2022 · Biosensors
85. Epidemiological Analysis of SARS-CoV-2 Transmission Dynamics in the State of Odisha, India: A Yearlong Exploratory Data Analysis
    Sourya Subhra Nasker, Ananya Nanda, Balamurugan Ramadass, Sasmita Nayak · 2021 · International Journal of Environmental Research and Public Health
86. Reduced amplification efficiency of the RNA-dependent-RNA-polymerase (RdRp) target enables tracking of the Delta SARS-CoV-2 variant using routine diagnostic tests
    Z. Valley-Omar, K. Marais, A. Iranzadeh et al. · 2021 · medRxiv
87. COVID-19: Not just another respiratory virus—2020
    Ian R. Tizard, Jeffrey M.B. Musser · 2022 · Elsevier eBooks
88. Mutation Interest in the Receptor-Binding Domain of Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2 in the Northwest of Iran
    Chiman Karami, Vahid Asghariazar, Yasamin Pahlavan, Kamyar Mazloum Jalali, Ahmad Tajehmiri, Mohammad GhorbaniVanan, Elham Safarzadeh · 2023 · Jundishapur Journal of Microbiology
89. Reconstructing early transmission networks of SARS-CoV-2 using a genomic mutation model
    Chao-Yuan Cheng, 中国科学院动物研究所农业虫害鼠害综合治理研究国家重点实验室, 北京 100101, 中国, Zhi-Bin Zhang, 中国科学院生物互作卓越创新中心, 北京 100049, 中国 · 2023 · 动物学研究
90. Evaluation of the Diagnostic Value of Hematologic Parameters and Ratios in SARS-CoV-2 VOC-202012/01 Mutant Population
    Murat Seyit, E. Avcı, A. Yılmaz · 2022 · Cureus
91. A High-Throughput Platform for Rapid Adaptation of DNA Aptamers to SARS-CoV-2 Evolution
    Yujie He, Zhenglin Yang, Yu-An Kuo, Yuting Wu, Diego Fonseca-Albert, Kyle K Le, Jeffrey G Guo, Yanxing Wang, Anh-Thu Nguyen, Yuan-I Chen et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
92. Unsupervised classification of SARS-CoV-2 genomic sequences uncovers hidden genetic diversity and suggests an efficient strategy for genomic surveillance
    Matteo Chiara, David Stephen Horner, Erika Ferrandi, Carmela Gissi, Graziano Pesole · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
93. Prognosis of patients with acute respiratory failure due to the SARS-CoV-2 501Y.V2 variant: a multicenter retrospective matched cohort study
    Bérénice Puech, Antoine Legrand, Olivier Simon, Chloé Combe, Marie‐Christine Jaffar‐Bandjee, Margot Caron, Charles Vidal, Patrick Mavingui, Renaud Blondé, Yvonnick Boué et al. · 2022 · Scientific Reports
94. Estimating the Incidence of SARS-CoV-2 Cases in Belize Based on Mortality Rate
    P. Morgan, Cyleen Morgan, Chieh Hsu · 2021 · Dr. Sulaiman Al Habib Medical Journal
95. Coronavirus disease 2019 pandemic two years later… What’s next?
    Rok Čivljak, A. Markotić · 2022 · Croatian Medical Journal
96. Effect of Coronavirus Disease 2019 on Fluorine-18 fluorodeoxyglucose Uptake of Endocrine Organs
    Ogün Bülbül, Sibel Göksel, Demet Nak · 2023 · Cumhuriyet Tıp Dergisi/Cumhuriyet Üniversitesi Tıp Fakültesi dergisi
97. Impfstoffe gegen COVID-19
    Anahita Fathi, Sibylle C. Mellinghoff · 2021 · Der Internist
98. Simulation study reveals factors that affect the predominance of SARS-CoV-2 novel variant
    Yuki Furuse · 2021 · Virology Journal
99. Discussion on “Estimating vaccine efficacy over time after a randomized study is unblinded” by Anastasios A. Tsiatis and Marie Davidian
    Holly E. Janes, Fei Gao, Alex R. Luedtke · 2021 · Biometrics
100. Genomic Analysis of AZD1222 (ChAdOx1) Vaccine Breakthrough Infections in the City of Mumbai
     Arusha Shetty, Gaurav Chatterjee, Sweta Rajpal, Tuhina Srivastava, Nilesh Gardi, Sumeet Prakash Mirgh, Anant Ganesh Gokarn, Sachin B. Punatar, Nitin Shetty, Amit D. Joshi et al. · 2022 · International Journal of Clinical Practice